Induction of antibodies against structural proteins of hepatitis C virus in mice using recombinant adenovirus

Vaccine

Volumn 14, Issue 1, 1996, Pages 28-34

  Makimura, M ^a   Miyake, S ^b,c   Akino, N ^a   Takamori, K ^b   Matsuura, Y ^a   Miyamura, T ^a   Saito, I ^b  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c TOHO UNIVERSITY   (Japan)

Author keywords

Hepatitis C virus; Recombinant adenovirus; Structural proteins

Indexed keywords

VIRUS ANTIBODY; VIRUS PROTEIN;

ADENOVIRUS; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPATITIS C VIRUS; IMMUNIZATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; VIRUS RECOMBINANT; VIRUS REPLICATION;

EID: 0030062317     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0264-410X(95)00161-S     Document Type: Article

References (39)

1. Choo, Q.-L., Kuo, G., Weiner, A.J., Overby, L.R., Bradley, D.W. and Houghton, M. Isolation of cDNA clone derived from a blood-borne non-A non-B viral hepatitis genome. Science 1989, 244, 359-362
2. Grakoui, A., Wychowski, C., Lin, C., Feinstone, S.M. and Rice, C.M. Expression and identification of hepatitis C virus polyprotein cleavage products. J . Virol. 1993, 67, 1385-1395
3. Miller, R.H. and Purcell, R.H. Hepatitis C virus shares amino acid sequence similarity with pestiviruses and flaviviruses as well as members of two plant virus supergroups. Proc. Natl Acad Sci. USA 1990, 87, 2057-2061
4. Alter, H.J. Chronic consequences of non-A, non-B hepatitis. In: Current Perspective in Hepatology (Eds Seeff, L.B. and Lewis, J.H.). Plenum Medical Books, New York, 1989, p. 83
5. Houghton, M., Weiner, A., Han, J., Kuo, G. and Choo, Q.-L. Molecular biology of the hepatitis C virus: implications for diagnosis, development, and control of viral disease. Hepatology 1991, 14, 381-388
6. Parkin, D.M., Stjernsward, J. and Muir, C.S. Estimates of the world wide frequency of twelve major cancers. Bull. WHO 1984, 62, 163-182
7. Saito, I., Miyamura, T., Ohbayashi, A. et al. Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc. Natl Acad. Sci. USA 1990, 87, 6547-6549
8. Graham, F.L., Smiley, J., Russell W.C. and Nairn, R. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 1977, 36, 59-72
9. Alkhatib, G. and Briedis, D. High level eucaryotic in vivo expression of biologically active measles virus hemagglutinin by using an adenovirus type 5 helper-free vector system. J. Virol. 1988, 62, 2718-2727
10. Ballay, A., Levrero, M., Buendia, M.A., Tiollais, P. and Perricaudet, M. In vitro and in vivo synthesis of the hepatitis B virus surface antigen and of the receptor for polymerized human serum albumin from recombinant human adenovirus. EMBO J. 1985, 4, 3861-3865
11. Chengalvala, M., Lubeck, M.D., Davis, A.R. et al. Evaluation of adenovirus type 4 and 7 recombinant hepatitis B vaccine in dogs. Vaccine 1991, 9, 485-490
12. Eloit, M., Gilardi-Hebenstreit, P., Toma, B. and Perricaudet, M. Construction of a defective adenovirus vector expressing the pseudorabies virus glycoprotein gp 50 and use as a live vaccine. J. Gen. Virol. 1990, 71, 2425-2431
13. Hsu, K.H.L., Lubeck, M., Davis, A.R. et al. Immunogenicity of recombinant adenovirus-respiratory syncytial virus vaccines with adenovirus type 4, 5, and 7 vectors in dogs and a chimpanzee. J. Infect. Dis. 1992, 166, 769-775
14. Levrero, M., Barban, V., Manteca, S. et al. Defective and nondefective adenovirus vectors for expressing foreign genes in vitro and in vivo. Gene 1991, 101, 195-202
15. Lubeck, M., Davis, A.R., Chengalvala, M. et al. Immunogenicity and efficacy testing in chimpanzees of an oral hepatitis B vaccine based on live recombinant adenovirus. Proc. Natl Acad. Sci. USA 1989, 86, 6763-6767
16. Mason, B.B., Davis, A.R., Bhat, B.M. et al. Adenovirus vaccine vectors expressing hepatitis B surface antigens: importance of regulatory elements in the adenovirus major late intron. Virology 1990, 177, 452-461
17. Morin, J.E., Lubeck, D., Barton, J.E., Conley, A.J., Davis, A.R. and Hung, P.P. Recombinant adenovirus induces antibody response to hepatitis B virus surface antigen in hamsters. Proc. Natl Acad. Sci. USA 1987, 84, 4626-4630
18. Ragot, T., Finerty, S., Watkins, P.E., Perricaudet, M. and Morgan, A.J. Replication-defective recombinant adenovirus expressing the Epstein-Barr virus (EBV) envelope glycoprotein gp340/220 induces protective immunity against EBV-induced lymphomas in the cottontop tamarin. J. Gen. Virol. 1993, 74, 501-507
19. Witmer, L.A., Rosenthal, K.L., Graham, F.L., Friedman, A.Y. and Johnson, D.C. Cytotoxic T lymphocytes specific for herpes simplex virus (HSV) studied using adenovirus vectors expressing HSV glycoproteins. J. Gen. Virol. 1990, 71, 387-396
20. Suzuki, R., Matsuura, Y., Suzuki, T. et al. Nuclear localization of the truncated hepatitis C virus core protein with its hydrophobic C-terminus deleted. J. Gen. Virol. 1995, 76, 53-61
21. Matsuura, Y., Harada, S., Suzuki, R. et al. Expression of processed envelope protein of hepatitis C virus in mammalian and insect cells. J. Virol. 1992, 66, 1425-1431
22. Matsuura, Y., Suzuki, T., Suzuki, R. et al. Processing of E1 and E2 glycoproteins of hepatitis C virus expressed in mammalian and insect cells. Virology 1994, 205, 141-150
23. Saito, I., Oya, Y., Yamamoto, K., Yuasa, T. and Shimojo, H. Construction of nondefective adenovirus type 5 bearing a 2.8-kilobase hepatitis B virus DNA near the right end of its genome. J. Virol. 1985. 54, 711-719
24. Miyake, S., Makimura, M., Kanegae, Y. et al. Efficient generation of recombinant adenoviruses using adenovirus DNA-terminal protein complex and a cosmid bearing full-length virus genome. Proc. Natl. Acad. Sci. USA 1996, in press
25. Sambrook, J., Fritsch, E.F. and Maniatis, T. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 1989
26. Harada, S., Watanabe, Y., Takeuchi, K. et al. Expression of processed core protein of hepatitis C virus in mammalian cells. J. Virol. 1991, 65, 3015-3021
27. Chiba, J., Ohba, H., Matsuura, Y. et al. Serodiagnosis of hepatitis C virus (HCV) infection with an HCV core protein molecularly expressed by a recombinant baculovirus. Proc. Natl Acad. Sci. USA 1991, 88, 4641-4645
28. Lanford, R.E., Notovall, L., Chavez, D. et al. Analysis of hepatitis C virus capsid, E1 and E2/NS1 proteins expressed in insect cells. Virology 1993, 197, 225-235
29. Ryan, M.D. and Drew, J. Foot-and-mouth disease virus 2A oligopeptide mediated cleavage of an artificial polyprotein. EMBO J. 1994, 13, 928-933
30. Manabe, S., Fuke, I., Tanishita, O. et al. Production of non-structural proteins of hepatitis C virus requires a putative viral protease encoded by NS3. Virology 1994, 198, 636-644
31. Ralston, R., Thudium, K., Berger, K. et al. Characterization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia viruses. J. Virol. 1993, 67, 6753-6761
32. Spaete, R.R., Alexander, D., Rugroden, M.E. et al. Characterization of the hepatitis C virus E2/NS1 gene product expressed in mammalian cells. Virology 1992, 188, 819-830
33. Tomei, L., Failla, C., Santolini, E., Francesco, R.D. and Monica, N.L. NS3 is a serine protease required for processing of hepatitis C virus polyprotein. J. Virol. 1993, 67, 4017-4026
34. Mizushima, H., Hizikata, M., Asabe, S., Hirota, M., Kimura, K. and Shimotono, K. Two hepatitis C virus glycoprotein E2 products with different C termini. Virology 1994, 68, 6215-6222
35. Matsuura, Y., Suzuki, R., Watanabe, Y. et al. Expression of E1 and E2/NS1 proteins of HCV in mammalian and insect cells. In: Vaccine 93 (Eds Chaunock, R.M., Ginsberg, H.S., Brown, F. and Lerner, R.A.). Cold Spring Harbor Laboratory Press, New York, 1993, pp. 289-294
36. Choo, Q-L., Kuo, G., Raiston, R. et al. Vaccination of chimpanzees against infection by the hepatitis C virus. Proc. Natl Acad. Sci. USA 1994, 91, 1294-1298
37. Shimizu, Y.K., Purcell, R.H. and Yoshikura, H. Correlation between the infectivity of hepatitis C virus in vivo and its infectivity in vitro. Proc. Natl Acad. Sci. USA 1993, 90, 6037-6041
38. Shimizu, Y.K., Hijitaka, M., Iwamoto, A., Alter, H., Purcell, R.H. and Yoshikura, H. Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses. J. Virol. 1994, 68, 1494-1500
39. Kato, N., Sekiya, H., Ootsumaya, Y. et al. Humoral immune response to hypervariable region 1 of the putative envelope glycoprotein (gp70) of hepatitis C virus. J. Virol. 1993, 67, 3923-3930